短生产周期、非基因毒性、基于 mRNA 的 CAR-T 细胞靶向 CD19 阳性和 CD22 阳性恶性肿瘤的表征
Characterization of Short Production Cycle and Nongenotoxic mRNA-Based CAR-T Cells Targeting CD19-Positive and CD22-Positive Malignancies.
44.7分
★★☆☆☆
站内排序·非疗效
ALL SOURCES
MEMBER ACCOUNT
登录成功会直接打开下一页。